ABEO vs RF
Abeona Therapeutics Inc (ABEO) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
RF does not have a complete income-statement cache yet.
ABEO currently screens at market cap $301.8M. RF currently screens at market cap $0.
Not investment advice. Open the ABEO and RF stock pages for the full models.
Not investment advice.